Maravai LifeSciences (MRVI) Tops Q4 EPS by 2c, Revenues Beat; Offers FY21 EPS/Revenue Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Maravai LifeSciences (MRVI) Tops Q4 EPS by 2c, Revenues Beat; Offers FY21 EPS/Revenue Guidance Above Consensus
(NASDAQ: MRVI) Delayed: 5.70 -0.08 (1.38%)
Previous Close $5.78    52 Week High $ 
Open $5.72    52 Week Low $ 
Day High $5.82    P/E N/A 
Day Low $5.55    EPS $ 
Volume 2,378,031